Synmosa Biopharma Free Cash Flow Generation Index
Synmosa Biopharma free cash flow generation index. Synmosa Biopharma (4114) has a Free Cash Flow Generation Index of 0.68x as of December 2025. Free cash flow of NT$126.26 Million represents 1% of operating cash flow (NT$185.72 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Synmosa Biopharma (2015–2025)
Free cash flow generation index of Synmosa Biopharma from 2015 to 2025. Historical FCF Generation Index trend for Synmosa Biopharma across 9 annual periods. See how financially flexible is Synmosa Biopharma to measure the company's free cash flow as a share of total liabilities.
Synmosa Biopharma Free Cash Flow Generation Index by Year (2015–2025)
Synmosa Biopharma free cash flow generation index by year from 2015 to 2025. Year-by-year Free Cash Flow Generation Index for Synmosa Biopharma. For the full cash flow conversion analysis, see Synmosa Biopharma cash flow conversion.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | NT$130.44 Million | NT$411.57 Million | NT$281.13 Million | ▼ -51.6% |
| 2024 | 0.65x | NT$510.97 Million | NT$780.62 Million | NT$269.65 Million | ▲ +38.4% |
| 2023 | 0.47x | NT$242.16 Million | NT$511.93 Million | NT$269.77 Million | ▼ -33.1% |
| 2022 | 0.71x | NT$445.92 Million | NT$630.25 Million | NT$129.29 Million | ▲ +4.0% |
| 2021 | 0.68x | NT$302.17 Million | NT$444.29 Million | NT$93.06 Million | ▲ +124.1% |
| 2020 | 0.30x | NT$77.20 Million | NT$254.40 Million | NT$154.41 Million | ▲ +101.4% |
| 2018 | -21.89x | NT$-350.16 Million | NT$16.00 Million | NT$314.43 Million | ▼ -883.9% |
| 2016 | 2.79x | NT$660.40 Million | NT$236.48 Million | NT$423.92 Million | ▼ -83.2% |
| 2015 | 16.65x | NT$392.86 Million | NT$23.60 Million | NT$369.26 Million | — |